Elenco degli articoli con argomento «Avelumab»
Dermatologia06 giu 2017
Triple Immunotherapy for Metastatic Merkel Cell Carcinoma Shows Promise
Three out of four patients treated with an experimental combination of 3 different therapies for metastatic Merkel cell carcinoma are in complete remission following the treatment, according to study that will be presented on June 5 at the 2017 Annual Meeting of the American Society of Clinical Oncology (ASCO)
18 apr 2017
Avelumab Provides Durable Responses in Patients With Distant Metastatic Merkel Cell Carcinoma
Avelumab provided durable responses in patients with distant metastatic Merkel cell carcinoma who had progressed after chemotherapy, according to a study presented here at the 2017 Annual Meeting of the American Association for Cancer Research (AACR)
03 apr 2017
FDA Approves Avelumab for Metastatic Merkel Cell Carcinoma
The US Food and Drug Administration (FDA) has granted accelerated approval to avelumab (Bavencio) for the treatment of patients aged 12 years and older with metastatic Merkel cell carcinoma (MCC).